EXPRESSION OF RECOMBINANT HUMAN ARGININOSUCCINATE SYNTHETASE IN ESCHERICHIA COLI
DOI: http://dx.doi.org/10.30970/sbi.0503.173
Abstract
Escherichia coli strain BL21(DE3)/pET42a/ASS – an efficient producer of recombinant human argininosuccinate synthetase (rhASS) – was constructed, and preparations of purified rhASS were obtained using His-tag affinity chromatography. The effect of specific inhibitor, α-methyl-DL-aspartate, and nitric oxide donor, sodium nitroprusside, on the ASS specific activity was evaluated with purified rhASS protein and in mouse liver lysates. The developed expression platform is a useful tool in search for new ASS inhibitors efficient under in vitro and in vivo conditions.
Keywords
Full Text:
PDFReferences
1. Berning C., Bieger I., Pauli S. et al. Investigation of Citrullinemia Type I Variants by In Vitro Expression Studies. Human Mutation, 2008; 29(10): 1222-1227. | |
| |
2. Bobak Y.P., Vynnytska B.O., Kurlishchuk Y.V. et al. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes. Cell Biol. Int, 2010; 34(11): 1085-1089. | |
| |
3. Chen O.I., Lyniv L.S., Igumentseva N.I. et al. Effect of nitric oxide donor on viability of human leukemic cells upon arginine deprivation. Studia Biologica, 2011; 5(2): 17-28. | |
| |
4. Cheng N.M., Leung Y.C., Lo W.H.: US Patent No. 20050244398. 2005. | |
| |
5. Cheng P.N., Lam T.L., Lam W.M. et al. Pegylated recombinant human arginase (rhArg-peg5000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res, 2007; 67: 309-317. | |
| |
6. Delage B., Fennell D.A., Nicholson L. et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int. J. Cancer, 2010; 126: 2762-2772. | |
| |
7. Dillon B.J., Prieto V.G., Curley S.A. et al. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer, 2004; 100: 826-833. | |
| |
8. Feun L., You M., Wu C.J. et al. Arginine Deprivation as a Targeted Therapy for Cancer. Curr Pharm. Des, 2008; 14(11): 1049-1057. | |
| |
9. Flam B.R., Eichler D.C., Solomonson L.P. Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide, 2007; 17: 115-121. | |
| |
10. Guerreiro J.R., Lameu C., Oliveira E.F. et al. Argininosuccinate Synthetase Is a Functional Target for a Snake Venom Anti-hypertensive Peptide. Role in arginine and nitric oxide production. J. Biol. Chem, 2009; 284(30): 20022-20033. | |
| |
11. Haberle J., Pauli S., Linnebank M. et al. Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia. Hum. Genet, 2002; 110: 327-333. | |
| |
12. Haines R.J., Pendleton L.C., Eichler D.C. Argininosuccinate synthase: at the center of arginine metabolism. Int. J. Biochem. Mol. Biol, 2011; 2(1): 8-23. | |
| |
13. Hao G., Xie L., Gross S.S. Argininosuccinate Synthetase is Reversibly Inactivated by S-Nitrosylation in Vitro and in Vivo. J. Biol. Chem, 2004; 279(35): 36192-36200. | |
| |
14. Husson A., Brasse-Lagnel C., Fairand A. et al. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur. J. Biochem, 2003; 270: 1887-1899. | |
| |
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227(259): 680-685. | |
| |
16. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem, 1977; 83: 346-356. | |
| |
17. Satoh M., Iwahori T., Sugawara N., Yamazaki M. Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities. J. Endotoxin Res, 2006; 12(1): 21-38. | |
| |
18. Shen L.-J., Beloussow K., Shen W.-C. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem. Pharmacology, 2005; 69: 97-104. | |
| |
19. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology, 1992; 24: 145-149. | |
| |
20. Wang P.G., Xian M., Tang X. et al. Nitric oxide donors: chemical activities and biological applications. Chem. Rev, 2002; 102(4): 1091-1134. | |
| |
21. Wheatley D.N. Controlling cancer by restricting arginine availability - arginine - catabolizing enzymes as anticancer agents. Anticancer Drugs, 2004; 15: 825-833. | |
| |
22. Xie L., Gross S. S. Argininosuccinate Synthetase Overexpression in Vascular Smooth Muscle Cells Potentiates Immunostimulant-induced NO Production. J. Biol. Chem, 1997; 272(26): 16624-16630. |
Refbacks
- There are currently no refbacks.
Copyright (c) 2011 Studia biologica
This work is licensed under a Creative Commons Attribution 4.0 International License.